Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

31

Revenue 2017

NovoRapid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. NovoRapid was produced by Novo Nordisk.

Ypsomed’s touch screen insulin pump for Novo Nordisk approved by EMA

Ypsomed’s touch screen insulin pump for Novo Nordisk approved by EMA

The mylife YpsoPump is fitted with a touch screen, reducing the need for training, and is fully compatible with Novo Nordisk's prefilled pump cartridge, NovoRapid PumpCart, which negates the need ... NovoRapid was awarded a European license in 1999 and

Prescribing costs jump in England

Prescribing costs jump in England After Seretide, another respiratory drug from AstraZeneca - Symbicort - saw the second highest spend with £89m, while Novo Nordisk's insulin NovoRapid came in third with the NHS spending £75m on the

Hanover wins Novo Nordisk public affairs and policy account

Hanover wins Novo Nordisk public affairs and policy account Novo has built its business on a range of diabetes, led by currently the insulins Levemir, NovoRapid and Tresiba and the GLP-1 agonist Victoza (liraglutide).

Novo Nordisk will build $100m facility in Denmark

Novo Nordisk will build $100m facility in Denmark These include Tresiba-based combination therapy IDegLira, which incorporates insulin degludec plus liraglutide (the API in GLP-1 agonist Victoza), a revamped version of fast-acting insulin product NovoLog/NovoRapid (insulin

EASD 2013: Novo Nordisk's diabetes combination IDegLira impresses in study

EASD 2013: Novo Nordisk's diabetes combination IDegLira impresses in study We have compared people failing on Tresiba to intensify them with either with a mealtime insulin such as NovoRapid or with Victoza as a GLP-1 agonist,” he said.

1 2 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics